CoChat
Sign Up
Cited by 123Medication Adherence and ComplianceLipoproteins and Cardiovascular HealthHealthcare Policy and Management

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Adherence to Statins, Subsequent Healthcare Costs, and Cardiovascular Hospitalizations

Pittman, Donald G., Chen, William, Bowlin, Steven J., Foody, JoAnne M.·2011·The American Journal of Cardiology
DOI 10.1016/j.amjcard.2011.01.052
Open this paper in CoChat — free account

Abstract

Statins are the primary agents used to decrease low-density lipoprotein cholesterol. Although adherence to statins improves the clinical outcomes, the affect of statin adherence on healthcare costs has not been well studied. To examine the relation among statin adherence, subsequent hospitalizations, and healthcare costs, we conducted a retrospective cohort study of 381,422 patients, aged 18 to 61 years, using an integrated pharmacy and medical claims database. We measured adherence using the medication possession ratio (MPR) for 12 months and the healthcare costs and cardiovascular disease-related hospitalizations during the subsequent 18 months. Of those studied, 258,013 (67.6%) were adherent (MPR ≥80%), 65,795 (17.3%) had an MPR of 60% to 79%, and 57,614 (15.1%) had an MPR of <60%. The adjusted all-cause total healthcare costs were lowest in the adherent group at $10,198 ± $39.4 (mean ± SE) versus $10,609 ± $77.7 (p <0.001) for an MPR of 60% to 79%, and $11,102 ± $84.3 (p <0.001) for an MPR of <60%. The adherent group had greater statin costs at $838 ± $1.0 versus $664 ± $2.0 (p <0.001) and $488 ± $2.2 (p <0.001). When evaluated by 5 levels of MPR, 0% to 59% and increments of 10% >60%, the adjusted total healthcare costs were lowest for the MPR 90% to 100% group and significantly greater statistically (p <0.001) for each lower level of adherence. Compared to the statin-adherent patients, cardiovascular disease-related hospitalizations were more likely for the patients with an MPR of 60% to 79% (odds ratio 1.12, 95% confidence interval 1.08 to 1.16) and an MPR of 0% to 59% (odds ratio 1.26, 95% confidence interval 1.21 to 1.31). In conclusion, statin adherence is associated with reductions in subsequent total healthcare costs and cardiovascular disease-related hospitalizations.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2011.01.052

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Flagged first, then by citations

Show all 21 references

Cited by

Sorted by citations

Items 101–123 of 123

Related

See all

Metadata

Authors
Pittman, D. G., Chen, W., Bowlin, S. J., & Foody, J. M.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Pittman, Donald G.
ORCID
Chen, William
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2011-06
Volume
107
Issue
11
Pages
1662-1666
ISSN
0002-9149 (ISSN-L)
DOI
10.1016/j.amjcard.2011.01.052
OpenAlex
W2150048145
Cited by
123
References
21
Citations by year
2026: 1 · 2025: 6 · 2024: 5 · 2023: 6 · 2022: 8 · 2021: 8 · 2020: 10 · 2019: 11 · 2018: 10 · 2017: 7 · 2016: 7 · 2015: 7 · 2014: 10 · 2013: 14 · 2012: 9
FWCI
10.46
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The American Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
Keywords
statin adherence, medication possession ratio, health care costs, cardiovascular hospitalization, cardiovascular disease, LDL cholesterol, medication adherence
MeSH terms
Adolescent, Adult, Female, Hospitalization, Humans, Male, Middle Aged, Retrospective Studies, Health Care Costs, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review